Brave scientists open their notebooks to help drive HD research at the risk of getting "scooped".
Huntingtin protein's structure is now clear thanks to cryo-electron microscopy. This is kind of a big deal
Updates from day 3 of the Huntington’s Disease Therapeutics Conference: huntingtin protein - and lowering it
DNA takes centre stage for day 2 of the Huntington's Disease Therapeutics Conference in Palm Springs
Our daily roundup of the science presented at the 2018 HD Therapeutics Conference in Palm Springs
A surprising new paper sheds light on the role of the HD gene early in development. Should we worry?
Promising results in mice provide renewed optimism for mGluR5 antagonists
In a Q&A coordinated by the UK HD Association, Dr Ed Wild answers questions on the recently-announced trial
Amazing news from Ionis and Roche! HTTRx drug successfully lowers harmful huntingtin protein in spinal fluid
CRISPR genome editing just got an off-switch. We cut through the hype to explore the technology in HD
Can we test drugs to delay or prevent the onset of Huntington's disease? New research suggests it's possible